Life Science News

  • WellteQ Digital Health Inc. (CSE: WTEQ / OTCQB: WTEQF) has signed a Letter of Intent (LOI) to commercialise sleep technology developed by Monash University, Australia to combat fatigue, insomnia, and burnout in shift worker employees.
  • Global Sleep Market Size to Reach Revenues of USD 137.16 Billion by 2026 1
  • Wellteq intends to integrate this intellectual property (IP) along with its recently announced licensed sleep technology into the Company's existing health assessment and coaching capabilities and create a market leading sleep and fatigue solution for employers and insurers globally.
  • Commercialisation efforts will initially focus on the aviation, healthcare, mining and construction sectors where workers are at heightened risk of excessive sleepiness at work and insomnia at home.
  • Monash University is a globally recognised university in Melbourne, Australia, which has researched and developed sleep IP for over seven-years and holds a patent application for this program.

WellteQ Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF) , (the "Company" or Wellteq"), which supplies digital health and wellness solutions to customers in 12 languages across 30 countries is pleased to announce an executed letter of intent for a Strategic Partnership to commercialize research and intellectual property for sleep assessment and coaching solutions with Monash University, Australia.

Monash University's Turner Institute for Brain and Mental Health, Deputy Director Professor Shantha Rajaratnam said: "We are delighted to explore a partnership with Wellteq, a company committed to improving health and wellbeing through digital solutions. We will work with Wellteq to deliver sleep-related products for improving workplace mental health and wellbeing, and also productivity."

Olly Bridge, Wellteq Chief Growth Officer stated: "Like most products, the best health coaching solutions require the latest scientific research combined with industry expertise. We are delighted to work with some of the world's leading sleep scientists and psychologists at Monash University, led by Professor Rajaratnam and his team within the Turner Institute for Brain and Mental Health."

Scott Montgomery, CEO of Wellteq, commented: "The Monash sleep technology license along with our recently announced license , are guided by our strategic focus on the four behavioural levers of health, and sleep is as important to one's health as nutrition, exercise and mental wellbeing. Even the best exercise routine, diet and mindset cannot sustain health without proper sleep."

Poor sleep is a significant contributor to mortality and morbidity including mental health, cardiac illness, metabolic conditions and some cancers. A recent journal in the Lancet disturbingly highlighted that sleep, anxiety, and depressive disorders have increased since the onset of the COVID-19 pandemic.

https://www.sciencedirect.com/science/article/pii/S2667193X21000016?via%3Dihub

In Australia, a Deloitte Access Economics report commissioned by the Sleep Health Foundation showed around 1 in 10 Australians have a sleep disorder that can substantially affect their well-being, safety and productivity, with an estimated overall cost of AUD$14.4 billion in financial costs with a further AUD$36.6 billion in non-financial costs related to poor wellbeing. A 2016 Study calculated that sleeplessness cost $411 billion per year in the US, equivalent to 2.28% of the US GDP at the time 2 . It's no wonder sleep market revenues are projected to exceed US$137 billion by 2026 1 .

Wellteq's mission is to coach the world to better health focusing on the four health levers – activity, nutrition, mindset and sleep. Through leveraging computer science, data science and health science, Wellteq believes they are fast approaching a tipping point where personalized, prevention focused solutions will engage people in all countries with healthier lifestyles, thus reducing behaviour related healthcare spend - a major economic strain and burden on healthcare systems the world over.

The Turner Institute for Brain and Mental Health is one of Australia's largest Institutes for brain and mental health and is based at Monash University. The Turner Institute's mission is to optimise brain and mental health through community driven, world leading research and innovative solutions.

About Monash University

Monash University is Australia's largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation. With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.

As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, Monash consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences. To learn more, visit monash.edu

About WellteQ Digital Health Inc.

WellteQ Digital Health Inc. is a leading global provider of personalized digital health and wellness solutions across the continuum of care. To learn more, visit http://www.wellteq.co .

Download the Wellteq Corporate Presentation: https://wellteq.co/about/investors/

1. Arizton Advisory & intelligence Sleep Market Report - Global Outlook and Forecast 2021-2026
2. Rand Corporation – 2016 https://www.rand.org/news/press/2016/11/30.html

Cautionary Note Regarding Forward-Looking Statements

This news release contains information or statements that constitute "forward-looking statements." Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

Forward looking information may include, without limitation, statements regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of wellteq, and includes statements about, among other things, future developments and the future operations, strengths and strategies of wellteq. Forward-looking information is provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These statements should not be read as guarantees of future performance or results.

The forward-looking statements made in this news release are based on management's assumptions and analysis and other factors that may be drawn upon by management to form conclusions and make forecasts or projections, including management's experience and assessments of historical trends, current conditions and expected future developments. Although management believes that these assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory, legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of the industry and product development; limited products; reliance on third parties; unfavourable publicity or consumer perception; general economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital requirements and liquidity; access to capital; the timing and amount of capital expenditures; the impact of COVID-19; shifts in the demand for wellteq's products and the size of the market; patent law reform; patent litigation and intellectual property; conflicts of interest; and general market and economic conditions.

The forward-looking information contained in this news release represents the expectations of wellteq as of the date of this news release and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. wellteq undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

The CSE has neither approved nor disapproved the contents of this news release.

Wellteq Investor Contact:

Glen Akselrod
Bristol Investor Relations
E: glen@bristolir.com
T: (905) 326-1888

News Provided by Business Wire via QuoteMedia

WellteQ Digital Health

WellteQ Digital Health

Overview

In 2020, the COVID-19 global pandemic shook traditional healthcare structures on a worldwide level. Not only did healthcare institutions need integrated systems to manage the influx of patients and personalized information, but companies needed to keep track of the wellness of their teams as large numbers of employees switched to remote work environments.

In this increasingly digital age, the sphere of telemedicine helped to not only revolutionize healthcare navigation but our perception of wellness management. Telemedicine has proven that the world could use innovative digital technologies to not only manage health complications but potentially proactively prevent them. As the global healthcare market is forecasted to grow to nearly US$11.9 trillion by 2022, investing in wellness technology today is investing in the healthcare of tomorrow.

WellteQ Digital Health (CSE:WTEQ) (OTCQB:WTEQF) is a digitally driven health and wellness company aiding the transition from old school healthcare navigation to a more personalized data-driven patient experience. Through data capture, artificial intelligence and analytics solutions, the company seeks to help people take control of their own wellness and overcome accessibility issues around health.

WellteQ customers currently include employers and insurance companies. In December 2020, Singapore reported stress alone can cost companies an estimated US$3.1 billion per year. To prevent such costs and ensure employee success, companies and insurers are making employee health and stress management major priorities for corporate wellness programs.

WellteQ's philosophy emphasizes rethinking wellness through preventative and proactive solutions instead of focusing on the reactionary treatment of health. In 2017, WellteQ partnered with Garmin to receive biometrics from Garmin's wearable biotech and incorporate that data into its advanced wellness portal and analytic solutions. Future generations of this technology combination are expected to support more health and wellness programming.

Operating out of one of the densest population zones in the world, the company also intends on expanding its APAC user base to larger worldwide markets. The completely digitally driven model means unlimited scalability and international localization. Likewise, WellteQ has designed its program to be a multifaceted digital solution that impacts every aspect of healthcare, including mental, behavioral and physiological health.

The company has plans to leverage the positive trends in telemedicine and upgrade its programming for a more unified user experience. The company has plans to upgrade their accessible API architecture to handle more data and integrated device connectivity. This optimization could allow algorithms to create a complete picture of health on an ongoing basis.

The growing WellteQ team consists of passionate professionals dedicated to innovating global health and telemedicine. With experience in commercial, medical and software engineering fields, the diverse team brings world-class expertise that has provided the foundation for its technical growth and economic success.

WellteQ Digital Health's Company Highlights

  • WellteQ is a digitally driven health and wellness company focused on providing users with programs that help them take back control of their health and engage in proactive and preventative wellness measures.
  • The employee wellness app is a software and hardware hybrid that incorporates an intuitive wellness portal with innovative wearables like Garmin, Apple Watch and FitBit.
  • Historically, WellteQ customers have been employers and insurance companies in Asia Pacific markets. The company has significant plans for global expansion with current operations in over 30 countries and counting.
  • WellteQ has partnered with tech giants like Garmin, Myfiziq, i-Screen, Savonix and Doctor Anywhere to create a fully integrated platform that helps track, assess and provide AI-driven analytics for its users and their employers and insurers.
  • Plans for 2021 and 2022 include expanding across the continuum of personalized care with added functions like chronic condition management.
  • Wellteq has signed a perpetual license agreement for sleep chronotype assessments and education content from one of Asia Pacific's leading sleep technology companies.
  • Dr. Peter W. Vaughan, CM, CD, MA, MD, MPH, ICD.D, Chairman of the Board of Directors at WellteQ Digital Health Inc. has been appointed to the Order of Canada.

WellteQ Employee Wellness App

The WellteQ specialized wellness software uses data sources inside the app and from wearable tech to create personalized profiles that coach users through an algorithm for risk-assessment and supportive lifestyle behaviors. This software-hardware hybrid for healthcare management has helped to address the high-demand for personalized and value-added digital health management which has proven to increase employee engagement by 40 percent.

Unlike traditional medical devices, this platform is personalized and customizable to specific wellness goals, and it is available in 13 languages and over 30 countries. WellteQ is committed to scalability in the global corporate wellness industry with plans for further expansion.

In partnership with reputable digital innovation companies, the WellteQ software app employs intelligent digital pathology that tracks key biomarkers for risk assessment, revolutionary 3D body imaging, neurocognitive assessment and virtual consultation functions. Along with additional gamified challenges, this employee smartphone app creates a unified user experience that is accessible on all mobile devices.

In 2021, the company plans on expanding its continuum of personalized care with the introduction of more premium care focused offerings. WellteQ+ will provide chronic condition management and virtual care functions that track chronic illness progression and treatment and monitor patient-specific data, including vitals.

WellteQ Digital Health's Management Team

Scott Montgomery - CEO/ Director/Co-Founder

Scott has performed at the highest level as an athlete, trainer and as a corporate leader for over 17 years having co-built and sold Onsite Health Solutions in 2012 (one of Australia & New Zealand's largest workplace wellness exits). Prior to Onsite, Scott was a Rehabilitation Case Manager with ACC New Zealand, the compulsory personal injury insurance scheme for all of New Zealand. Scott holds a bachelor's degree from the University of Otago.

Jeames Gillett - COO

Jeames brings 15 years of experience within the corporate wellness, insurance and population health sector. Jeames served as National Operations Manager for Onsite Health Solutions. Jeames also served as the National Service Delivery Manager for Vitality Works, a leading provider of Workplace Health Services across Australia & New Zealand. Jeames holds a Bachelor's degree from Stanford University in Exercise Physiology.

Andrew Kerekes - CPO

Andrew has over 20 years of experience in strategy, product design and delivery, sales and transformation. Andrew has held senior leadership positions within GE Capital, the financial services division of General Electric, LiveRamp and EVO, a privately held analytics platform for member health engagement and risk underwriting. Andrew holds a Bachelor's degree from La Trobe University in Psychology & Philosophy.

Daniel Starbuck - CTO

Daniel has over 15 years of experience building scalable enterprise business applications for domestic and international clients from start-ups to Fortune 500 companies. Daniel co-founded CBDS Health (now merged with WellteQ) in 2017.

Olly Bridge - Chief Growth Officer

Mr. Bridge comes to Wellteq from Medibank, Australia's largest health insurer, where he led the design and deployment of both their corporate and retail policy holder digital health and wellness programs. The Medibank digital health program has been deployed to 3.5 million policy holders. Prior to Medibank, Mr. Bridge led the global sales development for Global Corporate Challenge, which when acquired by Virgin Pulse in 2015, was operating in 185 countries around the world. Virgin Pulse are currently the world's largest corporate wellness provider.

Dr. Peter Vaughan - Chairman

Dr. Peter W. Vaughan is Board Chair of Canada Health Infoway and Chair of the Finance and Audit Committee, Treasurer, and Board member of the Supply Chain Advancement Network for Health (SCAN-H) at the University of Windsor Odette School of Business. Dr. Vaughan is former Deputy Minister of Health and Wellness, Province of Nova Scotia, former CEO of South Shore District Health Authority, former President, WebMD Canada, former CEO of the Canadian Medical Association, and former member the Government of Canada's Health/Bioscience Economic Strategy.

Dr Peter Vaughan, has been appointed to the Order of Canada by the Governor General of Canada. The Governor General cited the appointment of Dr Vaughan "for his contributions to Canada's health care system, and for his pioneering leadership in the establishment and advancement of digital health".

Dr Vaughan, who's career spans medicine, public healthcare, academia and multiple Board and Executive positions is recognized for his tenacious evangelism of healthcare modernization. Dr Vaughan was appointed Chairman of the Board of Directors for Wellteq just prior to the Company's listing on the Canadian Securities Exchange (CSE) in March 2021 and continues to lead the Company's execution to modernize healthcare delivery through the deployment of the Wellteq platform.

Brian Leeners - Co Founder/Director

Brian has been a technology entrepreneur since 1997. In 2007, he founded his first Internet of Things (IoT) company developing sensor and automation solutions for customers including Lowes, Control4, Steelcase and Schneider Electric. Recognizing the opportunity for the IoT in healthcare, Brian co-founded CBDS Health (now merged with WellteQ) in 2017. Brian's boutique venture capital and merchant banking firm has been responsible for +$75 million+ in venture financing.

Jacqueline Yee - Independent Director

Jacqueline has a global track record in mergers and acquisitions and structured finance. She is Managing Director at Macallan Capital, Non Executive Director of Mustang Energy Plc and Treasurer of Kidney Dialysis Foundation in Singapore. Former Financial Working Group Member of the Brain Cancer Foundation in Australia. Previously, signatory Director of BNP Paribas-Fortis United Kingdom and Netherlands and investment banker at Société Générale. Multilingual, a Chartered Accountant in Australia & New Zealand and summa cum laude graduate with Distinction award jointly conferred by the University of Amsterdam Graduate Business School and Graduate Faculty of Economics & Econometrics.

Andrea Johnson - Director

Andrea Johnson is a partner with Dentons Canada LLP and a member of its Canada region board of directors. Her practice focuses on corporate and securities law, with an emphasis on technology and emerging growth companies. Andrea has extensive experience in IPOs, corporate finance, M&A, venture capital and private equity, across sectors including fintech, software, telecommunications and health and life sciences. She has completed the Directors Education Program and is on the Ottawa chapter executive of the Institute for Corporate Directors (ICD). Andrea has received many rankings including from The Best Lawyers in Canada, Lexpert, Acritas, Chambers FinTech and The Legal 500 Canada.

Keep reading...Show less

CLASS ACTION UPDATE for AUPH, AMZN and UPST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you

AUPH Shareholders Click Here: https://www.zlk.com/pslra-1/aurinia-pharmaceuticals-inc-information-loss-submission-form?prid=27309&wire=1
AMZN Shareholders Click Here: https://www.zlk.com/pslra-1/amazon-com-inc-loss-submission-form?prid=27309&wire=1
UPST Shareholders Click Here: https://www.zlk.com/pslra-1/upstart-inc-loss-submission-form?prid=27309&wire=1

News Provided by ACCESSWIRE IA via QuoteMedia

Keep reading...Show less

FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV

All Clinical Studies Evaluating Injectable Lenacapavir to Resume –

– Decision Based on Review of Vial Compatibility Data –

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

ROSEN, A Top Ranked Law Firm, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021 and February 25, 2022, inclusive (the "Class Period"), of the important June 14, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Aurinia securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AbbVie Inc. Investors With Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action - ABBV

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ABBVie Inc. (NYSE: ABBV) between April 30, 2021 and August 31, 2021, inclusive (the "Class Period"), of the important June 6, 2022 lead plaintiff deadline.

SO WHAT: If you purchased AbbVie securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

IBM, ABBV, & TWTR Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm Reminds Shareholders to Actively Participate

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff

Bronstein, Gewirtz and Grossman, LLC, Monday, May 16, 2022, Press release picture

International Business Machines Corporation (NYSE:IBM)
Class Period: April 4, 2017 - October 20, 2021
Deadline: June 6, 2022
For more info: www.bgandg.com/ibm.

News Provided by ACCESSWIRE IA via QuoteMedia

Keep reading...Show less

SHAREHOLDER ALERT: CELH AUPH MULN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you

Celsius Holdings, Inc. (NASDAQ:CELH)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/celsius-holdings-inc-loss-submission-form?prid=27287&wire=1
Lead Plaintiff Deadline: May 16, 2022
Class Period: August 12, 2021 - March 1, 2022

News Provided by ACCESSWIRE IA via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×